Skip to content
AiViva BioPharma
  • Home
AiViva BioPharma
  • Home

Archive for August 2022

AiViva BioPharma Announces New Patent Received

By AiViva BioPharma | August 17, 2022
recent news

Newport Beach, California – August 15, 2022 – AiViva Biopharma, a clinical-stage biopharmaceutical company has received patent US 11,400,089 on August 2, 2022.  This patent is a method of use…

Read More

Recent Posts

  • Hannah Hershoff MD, PhD, has joined AiViva BioPharma as Chief Medical Officer
  • AiViva BioPharma Announces New Patent Received
  • AiViva BioPharma is recognized by Life Sciences Review as Top 20 Clinical-Stage Biopharmaceutical Company for 2022
  • AiViva BioPharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer
  • AiViva BioPharma Announces Positive Data from Phase 1/2a Clinical Trial of AIV001 for Dermal Scarring and Wound Healing  

Recent Comments

No comments to show.

Archives

  • September 2022
  • August 2022
  • May 2022
  • October 2020
  • June 2020

Categories

  • Uncategorized
© 2023 AiViva BioPharma | Powered by Beaver Builder
Scroll To Top